Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation

Scott Leischow, Fredrik Nilsson, Mikael Franzon, Anabel Hill, Pamela Otte, Elizabeth P. Merikle

Research output: Contribution to journalArticlepeer-review

59 Scopus citations


A randomized double-blind placebo-controlled clinical trial was conducted to assess the efficacy of a nicotine inhaler as an adjunct to smoking cessation. One hundred eleven subjects were randomized to each condition. Subjects received brief individual support regarding proper inhaler use and smoking cessation. Inhalers were used on an ad libitum dose for 3 months. Significant differences in abstinence rates between the two groups were found at 6 weeks, 3 months, and 6 months but not at 12 months after quit day. These results indicate that the nicotine inhaler is an efficacious adjunct to smoking cessation.

Original languageEnglish (US)
Pages (from-to)364-371
Number of pages8
JournalAmerican journal of health behavior
Issue number5
StatePublished - Dec 1 1996

ASJC Scopus subject areas

  • Health(social science)
  • Social Psychology
  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation'. Together they form a unique fingerprint.

Cite this